Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology.

Despite the increasing knowledge about the genetic alterations and molecular pathways involved in gliomas, few studies have investigated the association between the gene expression profiles (GEP) and both cytogenetics and histopathology of gliomas. Here, we analyzed the GEP (U133Plus2.0 chip) of 40 gliomas (35 astrocytic tumors, 3 oligodendrogliomas, and 2 mixed tumors) and their association with tumor cytogenetics and histopathology. Unsupervised and supervised analyses showed significantly different GEP in low- vs high-grade gliomas, the most discriminating genes including genes involved in the regulation of cell proliferation, apoptosis, DNA repair, and signal transduction. In turn, among glioblastoma multiforme (GBM), 3 subgroups of tumors were identified according to their GEP, which were closely associated with the cytogenetic profile of their ancestral tumor cell clones: (i) EGFR amplification, (ii) isolated trisomy 7, and (iii) more complex karyotypes. In summary, our results show a clear association between the GEP of gliomas and tumor histopathology; additionally, among grade IV astrocytoma, GEP are significantly associated with the cytogenetic profile of the ancestral tumor cell clone. Further studies in larger series of patients are necessary to confirm our observations.

[1]  B. Friguet,et al.  Overexpression of Mitochondrial Methionine Sulfoxide Reductase B2 Protects Leukemia Cells from Oxidative Stress-induced Cell Death and Protein Damage* , 2008, Journal of Biological Chemistry.

[2]  Ochi,et al.  Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas , 1998, Neuropathology and applied neurobiology.

[3]  Elisabet Englund,et al.  Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets , 2007, Journal of Neuro-Oncology.

[4]  P. Kleihues,et al.  Genetic profile of gliosarcomas. , 2000, The American journal of pathology.

[5]  Ülkü Öner,et al.  Genomic Alterations in Low-Grade , Anaplastic Astrocytomas and Glioblastomas , 2007 .

[6]  D. Louis,et al.  Activation of STAT3, MAPK, and AKT in Malignant Astrocytic Gliomas: Correlation With EGFR Status, Tumor Grade, and Survival , 2006, Journal of neuropathology and experimental neurology.

[7]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[8]  Alexander R. Pico,et al.  Pathway Analysis of Single-Nucleotide Polymorphisms Potentially Associated with Glioblastoma Multiforme Susceptibility Using Random Forests , 2008, Cancer Epidemiology Biomarkers & Prevention.

[9]  Ying Li,et al.  Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats , 2005, Cell.

[10]  A. Órfão,et al.  Intratumoral patterns of clonal evolution in gliomas , 2010, neurogenetics.

[11]  M. Lakomek,et al.  Induction of differentiation and tetraploidy by long-term treatment of C6 rat glioma cells with erucylphosphocholine. , 2001, International journal of oncology.

[12]  R. Pallini,et al.  Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme , 2008, International journal of cancer.

[13]  S. Horvath,et al.  Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.

[14]  E. Domany,et al.  Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  D. Housman,et al.  Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis , 2009, Proceedings of the National Academy of Sciences.

[16]  D. Gerlich,et al.  Aurora B-Mediated Abscission Checkpoint Protects against Tetraploidization , 2009, Cell.

[17]  R. Perona,et al.  Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a new approach , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[18]  A. Ribas,et al.  HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression , 2009, PLoS medicine.

[19]  N. Hashimoto,et al.  Gene Expression-Based Molecular Diagnostic System for Malignant Gliomas Is Superior to Histological Diagnosis , 2007, Clinical Cancer Research.

[20]  A. Korshunov,et al.  Molecular Stratification of Diagnostically Challenging High-Grade Gliomas Composed of Small Cells , 2004, Clinical Cancer Research.

[21]  T. Deuel,et al.  Dominant negative pleiotrophin induces tetraploidy and aneuploidy in U87MG human glioblastoma cells. , 2006, Biochemical and biophysical research communications.

[22]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[23]  I. Stagljar,et al.  The molecular role of the Rothmund-Thomson-, RAPADILINO- and Baller-Gerold-gene product, RECQL4: recent progress , 2007, Cellular and Molecular Life Sciences.

[24]  B. Bataille,et al.  Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study , 2008, British Journal of Cancer.

[25]  N. Probst-Hensch,et al.  Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas , 2004, Acta Neuropathologica.

[26]  E. Dougherty,et al.  Identification of combination gene sets for glioma classification. , 2002, Molecular cancer therapeutics.

[27]  A. Órfão,et al.  Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? , 2004, The Journal of molecular diagnostics : JMD.

[28]  Paul S Mischel,et al.  Gene expression profiling identifies molecular subtypes of gliomas , 2003, Oncogene.

[29]  Leszek Paczek,et al.  Gene expression profile as a prognostic factor in high-grade gliomas. , 2007, International journal of oncology.

[30]  D. Bigner,et al.  Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines. , 2008, Journal of immunological methods.

[31]  A. Órfão,et al.  Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas. , 2007, The oncologist.

[32]  Mitsutoshi Nakamura,et al.  Genetic analysis to complement histopathological diagnosis of brain tumors. , 2007, Histology and histopathology.

[33]  A. Chakravarti,et al.  Biomarkers of Clinical Responsiveness in Brain Tumor Patients , 2008, Molecular Diagnosis & Therapy.

[34]  K. Ichimura,et al.  Mutations in Rb1 pathway-related genes are associated with poor prognosis in Anaplastic Astrocytomas , 2005, British Journal of Cancer.

[35]  H. Zentgraf,et al.  BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosis , 2008, Apoptosis.

[36]  S. Franceschi,et al.  Correlation Among Pathology, Genotype, and Patient Outcomes in Glioblastoma , 2006, Journal of neuropathology and experimental neurology.

[37]  N. Zaffaroni,et al.  Targeting survivin in cancer therapy: fulfilled promises and open questions. , 2007, Carcinogenesis.

[38]  T. Golub,et al.  Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.

[39]  David E. Misek,et al.  Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. , 2003, The American journal of pathology.

[40]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[41]  Paul S Mischel,et al.  Molecular Analysis of Glioblastoma: Pathway Profiling and Its Implications for Patient Therapy , 2003, Cancer biology & therapy.

[42]  Cheng-guang Huang,et al.  Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors , 2008, Brain Research.

[43]  W. Gerald,et al.  Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70. , 2008, The American journal of pathology.

[44]  S. Moreno-Jimenez,et al.  Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study. , 2008, Annals of diagnostic pathology.

[45]  Michael E. Berens,et al.  Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion , 2008, Journal of Neuro-Oncology.

[46]  Y. Kishi,et al.  Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.

[47]  T. Rafnar,et al.  Gene Expression Analysis of Hematopoietic Progenitor Cells Identifies Dlg7 as a Potential Stem Cell Gene , 2007, Stem cells.

[48]  David N Louis,et al.  Molecular pathology of malignant gliomas. , 2006, Annual review of pathology.

[49]  S. Fukuda,et al.  Survivin, a cancer target with an emerging role in normal adult tissues , 2006, Molecular Cancer Therapeutics.